Market cap
$375 Mln
Market cap
$375 Mln
Revenue (TTM)
$931 Mln
P/E Ratio
--
P/B Ratio
4.4
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-1.8 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
52.3
Debt to Equity
54
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
16,198,000
CFO
$2,271.71 Mln
EBITDA
$3,986.73 Mln
Net Profit
$-1,046.22 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
MultiPlan Corporation Class A (MPLN)
| 48.6 | -6.6 | 74.8 | -27.4 | -50.8 | -- | -- |
|
BSE Sensex*
| -8.7 | 2.7 | -5.2 | -2.4 | 8.6 | 9.8 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
MultiPlan Corporation Class A (MPLN)
| -74.1 | 25.2 | -74.0 | -44.6 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based... services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York. Read more
Executive Chair
Mr. Dale A. White
CEO, President & Director
Mr. Travis S. Dalton
Headquarters
New York, NY
Website
The share price of MultiPlan Corporation Class A (MPLN) is $21.96 (NYSE) as of 27-Mar-2025 09:30 EDT. MultiPlan Corporation Class A (MPLN) has given a return of -50.77% in the last 3 years.
Since, TTM earnings of MultiPlan Corporation Class A (MPLN) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of MultiPlan Corporation Class A (MPLN) are Rs -- and Rs -- as of 27-Apr-2026.
MultiPlan Corporation Class A (MPLN) has a market capitalisation of $ 375 Mln as on 27-Mar-2025. As per SEBI classification, it is a Small Cap company.
Before investing in MultiPlan Corporation Class A (MPLN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.